Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapyThomas S. Uldrick, Sharon R. Lewin, Rémi Fromentin et al.|Science Translational Medicine|2022Cited by 101
Pomalidomide restores immune recognition of primary effusion lymphoma through upregulation of ICAM-1 and B7-2Prabha Shrestha, Robert Yarchoan|PLoS Pathogens|2021Cited by 39
Mechanism and therapeutic implications of pomalidomide-induced immune surface marker upregulation in EBV-positive lymphomasHannah K. Jaeger, Robert Yarchoan|Scientific Reports|2023Cited by 4